南方财经全媒体记者 杨雨莱 郑青亭 广州、北京报道
“China has a quite mature vaccine development in the manufacturing industry. It has a lot of vaccines in development. It has a lot of manufacturing capacity to provide vaccine supply that is needed in low-income developing countries.”
Melanie Saville, Chief Scientific Officer of PATHrecently has conducted an exclusive interview with SFC reporter, indicating that China has got the infrastructure, science, and technology to be quite a key player in the global health space.
During the interivew, Saville also revealed PATH's work in China now which is focused on promoting the development of the local vaccine and diagnostic industry, helping Chinese manufacturers comply with international laws and regulations, and produce related products in China at a lower cost.
After the experience of COVID-19, many governments and international organizations have set the goal as inventing a new vaccine in 100 days, when the next pandemic comes. “The 100-day mission is a really important ambitious goal,” Saville added that the way to achieve it is to do the Ramp;D upfront now, not wait for the emergency.
策划:于晓娜
监制:施诗
新媒体统筹:丁青云 曾婷芳 赖禧 曾昭发
海外运营监制: 黄燕淑
海外运营内容统筹: 黄子豪
海外运营编辑:庄欢 吴婉婕 龙李华 张伟韬
出品:南方财经全媒体集团
声明：免责声明：此文内容为本网站转载企业宣传资讯，仅代表作者个人观点，与本网无关。仅供读者参考，并请自行核实相关内容。
